References
- Sherry Ku M. (2008). Use of the biopharmaceutical classification system in early drug development. AAPS J, 10.
- ICH Topic Q3C (R4) Impurities: Guideline for Residual Solvents.
- Yalkowsky H. et al. (2001). Prediction of aqueous solubility of organic compounds by general solubility equation (gse). J Chem Comput Sci, 41:1208–1217.
- Van den Mooter G. (2011). The use of amorphous solid dispersions: A formulation strategy to overcome poor solubility and dissolution rate. Drug Discov Today: Technol. doi:10.1016/j.ddtec.2011.10.002.
- Saerens L. et al. (2011). Raman spectroscopy for the in-line polymer-drug quantification and solid state characterization during a pharmaceutical hot melt extrusion process. The Electronic Conference on Pharmaceutical Sciences ECPS2011.
- Aristides Da, Macheras P. (2006). A century of dissolution research: From Noyes and Whitney to the Biopharmaceutics Classification System. Int J Pharm, 321: 1–11.
- Kawabataa YB, Wadab K, Nakatanib M, Yamadaa S, Onouea S. (2011). Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications. Int J Pharm, 420: 1–10.
- Verreck G, Brewster ME. (2004). Melt extrusion-based dosage forms: excipients and processing conditions for pharmaceutical formulations. Bulletin Technique Gattefossé, 97.
- Leslie ZB, Chi-yuan WU, Joseph M, Custodio. (2006). Predicting drug absorption and the effects of food on oral bioavailability. Bulletin Technique Gattefossé, 99.